14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
Remuneration of Business-Related Travel Time in Germany - Precedential Decision by Judiciary or Reg...
Read More >
It is typical in private equity funds for certain tax-sensitive investors, including U.S. tax exempt...
Read More >
In In re Mindbody, Inc. Stockholders Litigation, the Delaware Court of Chancery declined to dismiss ...
Read More >
We include the 2018 chapter in its entirety for reference following the 2019 update. Background - ...
Read More >
The EEOC announced yesterday, September 12, 2019, that it “is not seeking to renew Component 2 of t...
Read More >
On November 22, 2019 the Consumer Financial Protection Bureau (CFPB) announced that it had filed a p...
Read More >